Institutional Ownership
Elevance Health Inc
CUSIP 036752103COMELVQ1 2026
Latest EPS (Diluted)
$6.71
Q2 2026 · Jun 30, 2026
Latest Revenue
$50.47B
Reported quarter
Latest Net Income
$1.46B
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Q2 2026 | $6.74 | $6.71 | $50.47B | $1.46B | 10-Q |
| Mar 31, 2026 | Q1 2026 | $8.03 | $8.00 | $50.18B | $1.76B | 10-Q |
| Sep 30, 2025 | Q3 2025 | $5.32 | $5.32 | $50.71B | $1.19B | 10-Q |
| Jun 30, 2025 | Q2 2025 | $7.74 | $7.72 | $49.78B | $1.74B | 10-Q |
| Mar 31, 2025 | Q1 2025 | $9.64 | $9.61 | $48.89B | $2.18B | 10-Q |
| Sep 30, 2024 | Q3 2024 | $4.38 | $4.36 | $45.11B | $1.02B | 10-Q |
| Jun 30, 2024 | Q2 2024 | $9.91 | $9.85 | $43.89B | $2.30B | 10-Q |
| Mar 31, 2024 | Q1 2024 | $9.65 | $9.59 | $42.58B | $2.25B | 10-Q |
| Sep 30, 2023 | Q3 2023 | $5.48 | $5.45 | $42.85B | $1.29B | 10-Q |
| Jun 30, 2023 | Q2 2023 | $7.83 | $7.79 | $43.67B | $1.85B | 10-Q |
| Mar 31, 2023 | Q1 2023 | $8.37 | $8.30 | $42.17B | $1.99B | 10-Q |
| Sep 30, 2022 | Q3 2022 | $6.69 | $6.62 | $39.94B | $1.60B | 10-Q |